Drug design, development and therapy

Drug Des Devel Ther · ISSN (e) 1177-8881 · 64 papers in corpus
observational 2019
doi:10.2147/dddt.s212235 ·PMID:31814708

OBJECTIVE: Frozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical ef…

observational 2019
doi:10.2147/dddt.s230129 ·PMID:32099323

PURPOSE: Dydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinologi…

lab-animal 2018
doi:10.2147/dddt.s162541 ·PMID:29922037

PURPOSE: Adenomyosis has a negative impact on female fertility. GnRH agonist treatment can improve pregnancy outcomes in women with adenomyosis. However, the impact of GnRH agonist upon endometrium receptivity of patients with adenomyosis r…

lab-animal 2018
doi:10.2147/dddt.s166330 ·PMID:30122900

Bevacizumab, which is a humanized anti-VEGF antibody, has been successfully applied in clinics since 2004. Bevacizumab in combination with chemotherapy showed high safety and has been applied to solid tumors. However, studies on the insight…

review 2017
doi:10.2147/dddt.s142475 ·PMID:29066865

Neuropathic pain (NP) is a complex and chronic disease caused by lesions or defects of the somatosensory nervous system. The treatments normally used for managing NP usually lack efficacy. Several animal models of NP have been engineered in…

lab-animal 2017
doi:10.2147/dddt.s127889 ·PMID:28331289

PURPOSE: Adenomyosis is a common, benign gynecological condition of the female reproductive tract characterized by heavy menstrual bleeding and dysmenorrhea. Gonadotropin-releasing hormone (GnRH) agonists are one of the medications used in …

other 2016
doi:10.2147/dddt.s103824 ·PMID:27822014

Postsurgical adhesion formation is the most common complication in abdominal and pelvic surgery. Adhesiolysis is the most commonly applied treatment for adhesion formation but is often followed by adhesion reformation. Therefore, an efficie…

observational 2016
doi:10.2147/dddt.s104104 ·PMID:27563236

The first PIVET algorithm for individualized recombinant follicle stimulating hormone (rFSH) dosing in in vitro fertilization, reported in 2012, was based on age and antral follicle count grading with adjustments for anti-Müllerian hormone …

observational 2016
doi:10.2147/dddt.s105607 ·PMID:27274202

Decreasing the dose of human chorionic gonadotropin (hCG) used to trigger final oocyte maturation in assisted reproductive technology programs is regarded as a useful intervention in the prevention of ovarian hyperstimulation syndrome, but …

lab-animal 2015
doi:10.2147/dddt.s90706 ·PMID:26345723

In the present study, solid dispersion nanoparticles with a hydrophilic polymer and surfactant were developed using the supercritical antisolvent (SAS) process to improve the dissolution and oral absorption of megestrol acetate. The physico…

lab-animal 2015
doi:10.2147/dddt.s76835 ·PMID:25834392

OBJECTIVES: To examine the effect of 95% ethanol sclerotherapy (EST) administered over 5 minutes on cyst diameter and ovarian tissue in experimentally induced simple ovarian cysts in a rat model. MATERIALS AND METHODS: In order to induce o…

lab-animal 2014
doi:10.2147/dddt.s67300 ·PMID:25152615

PURPOSE: Estrogens play important roles in the pathogenesis and progression of breast cancer as well as estrogen-related diseases. Aromatase is a key enzyme in the rate-limiting step of estrogen production, in which its inhibition is one st…

review 2014
doi:10.2147/dddt.s71227 ·PMID:25422584

For years, phosphodiesterase type 5 inhibitors have been used for the treatment of erectile dysfunctions. Due to the similarities between male and female sexual response, several studies have assessed the effects of sildenafil citrate (Viag…

other 2009
·PMID:19920891

BACKGROUND: Anthroposophic medications (AMED) are prescribed in 56 countries. OBJECTIVE: To study clinical outcomes in patients prescribed AMED for chronic disease. DESIGN: Prospective cohort study. SETTING: 110 medical practices in Germ…